Medicare Enrolled
Dr. Akif Mohammed, MD
Cardiovascular Disease · Fort Worth, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mohammed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohammed? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mohammed
Dr. Akif Mohammed is a cardiovascular disease in Fort Worth, TX, with 17 years in practice. Based on federal Medicare data, Dr. Mohammed performed 4,482 Medicare services across 3,488 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mohammed received a total of $7,660 from 38 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mohammed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 20% volume in TX$ $7,660 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,482
Medicare services
Top 20% in TX for cardiovascular disease
3,488
Unique beneficiaries
$143
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~264 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 665 | $89 | $218 |
| Regadenoson injection (Lexiscan) for heart stress test | 414 | $40 | $58 |
| Electrocardiogram (EKG), 12-lead | 341 | $10 | $26 |
| Office visit, established patient (20-29 min) | 273 | $56 | $154 |
| Echocardiogram, transthoracic | 184 | $131 | $338 |
| Cardiac catheterization | 170 | $176 | $482 |
| Office visit, established patient, complex (40-54 min) | 161 | $124 | $306 |
| EKG interpretation and report | 131 | $4 | $121 |
| Ultrasound of leg arteries or artery grafts | 122 | $168 | $414 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 118 | $324 | $755 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 118 | $54 | $138 |
| Ultrasound study of arm and leg arteries | 117 | $50 | $141 |
| Injection, midazolam hydrochloride, per 1 mg | 116 | $0 | $5 |
| New patient office visit (45-59 min) | 113 | $111 | $284 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 101 | $11 | $25 |
| Coronary stent placement | 99 | $410 | $961 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 99 | $16 | $39 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 99 | $20 | $60 |
| Hospital follow-up visit, moderate complexity | 96 | $59 | $135 |
| Prothrombin time test (blood clotting) | 95 | $4 | $10 |
| Initial hospital admission, moderate complexity | 90 | $92 | $221 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 82 | $9 | $100 |
| Ultrasound of both sides of head and neck blood flow | 75 | $129 | $329 |
| Injection, fentanyl citrate, 0.1 mg | 70 | $1 | $5 |
| Ultrasonic guidance for blood vessel access | 42 | $31 | $150 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 40 | $40 | $250 |
| Initial hospital admission, high complexity | 38 | $123 | $295 |
| Review by radiologist of arm or leg artery image | 36 | $115 | $500 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 36 | $134 | $325 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 34 | $19 | $46 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 33 | $194 | $547 |
| Ultrasound of heart, follow-up | 28 | $71 | $169 |
| Removal of plaque in arteries of leg | 24 | $4,509 | $35,000 |
| Removal of plaque in artery of leg, initial vessel | 24 | $6,503 | $33,000 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 22 | $86 | $206 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 21 | $238 | $612 |
| Hospital follow-up visit, high complexity | 21 | $92 | $202 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 19 | $49 | $125 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 18 | $816 | $1,859 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $18 | $48 |
| New patient office visit, complex (60-74 min) | 16 | $161 | $374 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $71 | $155 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $82 | $419 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $14 | $33 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $2 | $6 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $54 | $123 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.8% high complexity
33.3% medium
54.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,660
Total received (2018-2024)
Avg $1,094/year across 7 years
Top 38% in TX for cardiovascular disease
38
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,981 (91.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$680 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,421
2023$583
2022$1,475
2021$1,344
2020$691
2019$1,248
2018$899
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,608
Novartis Pharmaceuticals Corporation
$1,033
Impulse Dynamics (USA) Inc.
$680
E.R. Squibb & Sons, L.L.C.
$526
Amgen Inc.
$440
PFIZER INC.
$413
Boston Scientific Corporation
$380
Medtronic Vascular, Inc.
$380
AstraZeneca Pharmaceuticals LP
$288
Amarin Pharma Inc.
$239
Cardiovascular Systems Inc.
$221
SANOFI-AVENTIS U.S. LLC
$192
HeartFlow, Inc.
$166
Penumbra, Inc.
$149
Janssen Pharmaceuticals, Inc
$110
Edwards Lifesciences Corporation
$85
Cleerly, Inc.
$80
Actelion Pharmaceuticals US, Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
Alnylam Pharmaceuticals Inc.
$64
Regeneron Healthcare Solutions, Inc.
$62
Inari Medical, Inc.
$59
Philips North America LLC
$53
Tactile Systems Technology Inc
$33
BOSTON SCIENTIFIC CORPORATION
$31
Astellas Pharma US Inc
$30
Merck Sharp & Dohme LLC
$29
Esperion Therapeutics, Inc.
$27
Avinger Inc.
$20
Kiniksa Pharmaceuticals, Ltd.
$19
W. L. Gore & Associates, Inc.
$18
ABIOMED
$15
Siemens Medical Solutions USA, Inc.
$13
United Therapeutics Corporation
$12
Novo Nordisk Inc
$12
Merck Sharp & Dohme Corporation
$11
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$10
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 43.3% of total payments
Associated products mentioned in payments ›
(BR5) Peripheral IVUS · ABSOLUTE PRO · ACUSON Sequoia Diagnostic Ultrasound System · ANDEXXA · BRILINTA · CAMZYOS · CARDIOMEMS · COROFLOW · Carnation Ambulatory Monitor · Cleerly Ischemia · Confirm Rx · Corlanor · ELIQUIS · EMBOSHIELD NAV6 · ENSITE · ENTRESTO · FARXIGA · FFRct · FLEXITOUCH · FLOWTRIEVER CATHETER · GENERAL ANGIOGRAPHY · GENERAL - THERAPIES · GIVLAARI · General - Therapies · HawkOne · IN.PACT Admiral · Impella · Indigo · JARDIANCE · LEQVIO · LEXISCAN · LifeVest · MITRACLIP · MULTAQ · NC TREK coronary catheters · NEXLETOL · ONPATTRO · OPSUMIT · OptiCross · Optimizer Smart System · Optis Coronary Imaging System · Ozempic · PANTHERIS · PASCAL · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESSUREWIRE · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · PressureWire FFR · Promus ELITE · QT Vascular Chocolate PTA Balloon · Repatha · Resolute · Reveal LINQ · S · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · UPTRAVI · VERQUVO · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VYNDAQEL · Vascepa · WATCHMAN · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $171 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
102
Per 100K population
4.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mohammed is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mohammed experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mohammed performed 665 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohammed receive payments from pharmaceutical companies?
Yes. Dr. Mohammed received a total of $7,660 from 38 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohammed's costs compare to other cardiovascular diseases in Fort Worth?
Dr. Mohammed's average Medicare payment per service is $143. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohammed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Fort Worth
Browse cardiovascular diseases in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Impulse Dynamics (USA) Inc. Payments to Doctors
See all physicians who received payments from Impulse Dynamics (USA) Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology